Uthever® NMN NOVEL FOOD Update Download Whitepaper

Overview


EFFEPHARM

NMN is a precursor to NAD+. NAD+ is crucial for energy production, DNA repair, and regulating various cellular processes.

Uthever® NMN, the world’s first large-scale, human clinically-proven NMN brand, has completed the EU NOVEL FOOD Public Consultation. Uthever® is pioneering the EU NOVEL FOOD application process as the first NMN brand to enter the risk assessment stage and is now pending approval. Contact us to plan ahead and get your product market-ready.

Download the whitepaper for industry insights, the latest scientific findings on NMN, and comprehensive global regulatory information.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Your Product Innovation Begins Here: Booth 4555

Your Product Innovation Begins Here: Booth 4555

Content provided by Effepharm Ltd

Product Brochure

EffePharm will showcase innovative anti-aging solutions, including UthPeak™ reduced NMN (NMNH), the first Self-GRAS approved, US patent-pending reduced NMN.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.